Elevai Labs, Inc. (ELAB)

Market Cap	10.81M
Revenue (ttm)	2.18M
Net Income (ttm)	-4.62M
Shares Out	18.89M
EPS (ttm)	-0.37
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,785
Open	0.580
Previous Close	0.598
Day's Range	0.572 - 0.589
52-Week Range	0.570 - 4.244
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2024

About ELAB

Elevai Labs Inc., a skincare development company, designs, manufactures, and markets skincare products in the United States. The company offers Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. It serves dermatologists, plastic surgeons, medical spa owners, and physicians focused on aesthetic and therapeutic skincare. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs Inc. was incorporated in 2020 and is based in...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Nov 21, 2023
• Employees: 18
• Stock Exchange: NASDAQ
• Ticker Symbol: ELAB

Financial Performance

In 2023, Elevai Labs's revenue was $1.71 million, an increase of 123.50% compared to the previous year's $766,277. Losses were -$4.30 million, 138.9% more than in 2022.